Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart Project
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Silesia
About this trial
This is an observational longitudinal study which will collect routine demographic, laboratory and clinical parameters of patients with chronic kidney disease (CKD) in the Silesian and Warmia and Mazury Regions (Poland) aimed at predicting incident cardiovascular disease and cardiovascular and renal events using machine learning and artificial intelligence approaches. There will be a subgroup analysis of patients with diabetes and CKD.
Eligibility criteria
Qualifiers
CKD defined as estimated glomerular filtration rate (eGFR) < 60ml/min/1.73 m2 and/or urine albumin creatinine ratio ( UACR) > 30 mg/g lasting at least 3 months
CKD regardless of eGFR/albuminuria when documented otherwise (by means of imaging, renal biopsy result, genetic background, etc)
Disqualifiers
Death during hospital stay
Terminal stage of cancer
Lack of an informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Medical University of Silesia
Lead sponsor
University of Warmia and Mazury in Olsztyn
Collaborator
University of Liverpool
Collaborator
Source ClinicalTrials.gov